Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study.
Solidoro P, Patrucco F, de Blasio F, Brussino L, Bellocchia M, Dassetto D, Pivetta E, Riccio A, Heffler E, Canonica W, Rolla G, Bucca C.
Solidoro P, et al. Among authors: bucca c.
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619841274. doi: 10.1177/1753466619841274.
Ther Adv Respir Dis. 2019.
PMID: 31002021
Free PMC article.